Grantham, Mayo, Van Otterloo & Co (GMO)’s Kezar Life Sciences KZR Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,032	Closed	-$608K	–	708
2021 Q3	$608K	Sell	7,032 -4,950	-41%	-$328K	﹤0.01%	574
2021 Q2	$651K	Sell	11,982 -310	-3%	-$17.6K	﹤0.01%	581
2021 Q1	$733K	Sell	12,292 -1,828	-13%	-$107K	﹤0.01%	639
2020 Q4	$737K	Buy	14,120 +7,410	+110%	+$412K	﹤0.01%	616
2020 Q3	$325K	Buy	6,710 +5,110	+319%	+$244K	﹤0.01%	681
2020 Q2	$83K	Buy	+1,600	New	+$80.7K	﹤0.01%	729

Other funds holding KZR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s KZR Position: Q4 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Kezar Life Sciences (KZR) in Q4 2021, closing a stake of 7,032 shares — an estimated $608K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in KZR in Q2 2020 and held it in 6 quarters. The position peaked at $737K in Q4 2020. 107 funds tracked by Wall St. Rank hold KZR as of Q4 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Kezar Life Sciences position as of Q4 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,032 Kezar Life Sciences shares in Q4 2021, an estimated $608K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Kezar Life Sciences in Q2 2020 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Kezar Life Sciences position peaked at $737K in Q4 2020.
107 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2021, filed 11 Feb 2022.